Zoetis ZTS
NYSE ZTS
$73.43 -0.13 (-0.18%)
As of: Sep 9, 2026 · 3:06 PM EDT

Zoetis (ZTS) Share-based Compensation (2012 - 2026)

Zoetis' (ZTS) quarterly Share-based Compensation came in at $92.0 million in Q2 2026, down 31.85% year-over-year from $135.0 million in Q2 2025, and up 39.39% quarter-over-quarter from $66.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Share-based Compensation (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Share-based Compensation for 15 consecutive years, with $92.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Share-based Compensation fell 31.85% year-over-year to $92.0 million in Q2 2026; TTM through Jun 2026 was $142.0 million, a 34.86% decrease from a year earlier, with the FY2025 full-year figure at $165.0 million, up 122.97% from the prior year.
  • Share-based Compensation was $92.0 million for Q2 2026 at Zoetis, up from $66.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $135.0 million in Q2 2025 and troughed at -$24.0 million in Q4 2023.
  • A 5-year average of $30.8 million and a median of $19.0 million in 2022 frame the typical range for Share-based Compensation.
  • The widest YoY moves for Share-based Compensation: up 640.0% in 2023, down 250.0% in 2023.
  • Over 5 years, Share-based Compensation stood at $16.0 million in 2022, then tumbled by 250.0% to -$24.0 million in 2023, then surged by 179.17% to $19.0 million in 2024, then sank by 152.63% to -$10.0 million in 2025, then jumped by 1020.0% to $92.0 million in 2026.
  • The last three Share-based Compensation figures came in at $92.0 million (Q2 2026), $66.0 million (Q1 2026), and -$10.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Idexx Laboratories 40.49 Bn 40.29 Bn 779.09 Mn 16.09 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 92.00 Mn
3 Elanco Animal Health 11.82 Bn 11.29 Bn 798.00 Mn 7.00 Mn
4 Phibro Animal Health 1.51 Bn 1.42 Bn 134.40 Mn 413,000.00
5 Immucell 89.92 Mn 81.06 Mn 2.44 Mn 239,867.00
6 Zhengye Biotechnology Holding 75.76 Mn 68.66 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92.00 Mn
Mar 31, 2026 66.00 Mn
Dec 31, 2025 -10.00 Mn
Sep 30, 2025 -6.00 Mn
Jun 30, 2025 135.00 Mn
Mar 31, 2025 46.00 Mn
Dec 31, 2024 19.00 Mn
Sep 30, 2024 18.00 Mn
Jun 30, 2024 19.00 Mn
Mar 31, 2024 18.00 Mn
Dec 31, 2023 -24.00 Mn
Sep 30, 2023 37.00 Mn
Jun 30, 2023 58.00 Mn
Mar 31, 2023 24.00 Mn
Dec 31, 2022 16.00 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 22.00 Mn
Mar 31, 2022 19.00 Mn
Dec 31, 2021 14.00 Mn
Sep 30, 2021 5.00 Mn